|
|
|
¼º¼Ò·É ( Seong So-Ryoung ) - ¼¿ï¾Æ»êº´¿ø °£È£ºÎ
À̳²ÁÖ ( Lee Nam-Ju ) - ¼¿ï¾Æ»êº´¿ø °£È£ºÎ À̹ÌÁø ( Lee Mi-Jin ) - ¼¿ï¾Æ»êº´¿ø °£È£ºÎ ÀåÇö¾Æ ( Jang Hyun-Ah ) - ¼¿ï¾Æ»êº´¿ø °£È£ºÎ ¼Û¹ÎÁÖ ( Song Min-Ju ) - ¼¿ï¾Æ»êº´¿ø °£È£ºÎ ¹Ú¼¼Á¤ ( Park Se-Jung ) - ¼¿ï¾Æ»êº´¿ø °£È£ºÎ ±èÁöÀ± ( Kim Jee-Yoon ) - ¼¿ï¾Æ»êº´¿ø °£È£ºÎ ·ù¹é·Ä ( Ryoo Baek-Yeol ) - ¼¿ï¾Æ»êº´¿ø Á¾¾ç³»°ú
|
|
Abstract
|
|
|
|
Purpose: This study was performed to examine vascular pain due to gemcitabine and according to clinical factors.
Methods: The survey was performed with 525 cancer patients visiting chemotherapy infusion room in one general hospital. The data were collected via self-reported questionnaire, researchers observation, and reviewing medical records. Data were analyzed descriptive statistics, ttest, Kruskal-Wallis test, Tukey test using ranks, Jonckheere-Terpstra test, and Spearman correlation analysis were used.
Results: The mean scores of the intensity and onset time of vascular pain were 3.06¡¾2.16 and 8.13¡¾13.13 min, and each other were negative correlaton. Degree of intensity of vascular pain had a significant difference on gender (p=.003), age (p=.004), weight (p=.019), Body mass index (BMI) (p=.005), Body surface area (BSA) (p=.030), infusion time (p<.001), dose (p=.027), dose per minute (p<.001), the number of administered gemcitabine (p=.005), combination chemotherapeutic drug (p=.013) and tumor type (p=.002). Degree of onset time of vascular pain had a significant difference on infusion time (p=.044), combination chemotherapy (p=.001) and injection site (p=.001).
Conclusion: Patients administrated gemcitabine were experiencing various vascular pain, and vascular pain had a difference on clinical factors. Therefore, oncology nurses should be considered significant clinical factors to implement effective interventions to patients administered gemcitabine.
|
|
KeyWords
|
|
Áª½ÃŸºó, Ç÷°üÅë, ¾Ï ȯÀÚ
Gemcitabine, Vascular, Pain, Neoplasms
|
|
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
|
|
|
|
µîÀçÀú³Î Á¤º¸
|
|
|
|
|
|